Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cervical Cancer

Copper IUD Use Associated with Decreased Cervical Cancer Risk Compared Hormonal Intrauterine System

Ryan McDonald

Women who use copper intrauterine devices (IUD) as a form of birth control may be at lower risk for high-grade cervical cancer compared with those who use a levonorgestrel-releasing intrauterine system.

World Health Organization Outlines Plan to Eliminate Cervical Cancer in Low to Middle Income Countries

Conor Killmurray

The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.

World Cancer Day: 6 Hot Topics Making An Impact In Cancer

Conor Killmurray

For World Cancer Day, here are 6 hot topics making an impact in the cancer space.

CURE's Clinical Trial Corner: Cervical Cancer Edition

Jessica Skarzynski

Here is a list of clinical trials that are currently happening within the cervical cancer space.

Women Should Be Screened for Cervical Cancer Even as They Age

Katie Kosko

Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.

Self-Testing for HPV Could Help Reduce Cervical Cancer Rates

Tom Castles

A new study suggests distributing self-testing kits by mail helps bring effective testing to underserved populations and makes it easier for women to get tested on their own time.

At-Home Urine Test Could Replace Pap Smear for Cervical Pre-Cancer Screening

Tom Castles

Results from a new study suggest there may be a simpler, cheaper, more accessible way to screen for cervical pre-cancer.

Examining Genomics in the Treatment of Cervical Cancer

Katie Kosko

Researchers from Yale Cancer Center have created a platform to identify genetic mutations that might drive cervical cancer.

Clinical Trial Is Enrolling Patients With Cervical Cancer for Investigational Immunotherapy

Katie Kosko

Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.

Combination Immunotherapy Shows Promise in Cervical Cancer

Katie Kosko

Patients with recurrent or metastatic cervical cancer were treated with combination Opdivo and Yervoy in the CheckMate-358 clinical trial.

Cervical Cancer

Sign In